Author:
Finazzi G,Carobbio A,Thiele J,Passamonti F,Rumi E,Ruggeri M,Rodeghiero F,Randi M L,Bertozzi I,Vannucchi A M,Antonioli E,Gisslinger H,Buxhofer-Ausch V,Gangat N,Rambaldi A,Tefferi A,Barbui T
Publisher
Springer Science and Business Media LLC
Subject
Oncology,Cancer Research,Hematology
Reference15 articles.
1. Epstein E, Goedel A . Hämorrhagische thrombocythämie bei vasculärer schrumpfmilz. Virchows Arch f path Anat Physiol f klin Med 1934; 292: 233–248.
2. Wolanskyj AP, Lasho TL, Schwager SM, McClure RF, Wadleigh M, Lee SJ et al. JAK2V617F mutation in essential thrombocythemia: clinical associations and long-term prognostic relevance. Br J Haematol 2005; 131: 208–213.
3. Alvarez-Larran A, Cervantes F, Pereira A, Arellano-Rodrigo E, Pérez-Andreu V, Hernandez-Boluda J-C et al. Observation versus antiplatelet therapy as primary prophylaxis for thrombosis in low-risk essential thrombocythemia. Blood 2010; 116: 1205–1210.
4. Elliott MA, Tefferi A . Thrombosis and haemorrhage in polycythaemia vera and essential thrombocythaemia. Br J Haematol 2005; 128: 275–290.
5. Murphy S, Peterson P, Iland H, Laszlo J . Experience of the Polycythemia Vera Study Group with essential thrombocythemia: a final report on diagnostic criteria, survival and leukemic transition by treatment. Semin Hematol 1997; 34: 29–39.
Cited by
145 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献